We are dedicated to providing resources to patients, practicing clinicians, and all individuals concerned w/ improving the care of patients with kidney disease.

Joined September 2021
92 Photos and videos
❓ True or False: Kidneys only help with filtering waste. (Answer in the comments!)
Life is all about balance — just ask your nephrons.
1
Insight of the Week - Kidney care is evolving—new IgA nephropathy targets, advanced diagnostics like mNGS, and precision medicine are driving earlier detection & tailored treatments for better outcomes. Support research & advocate for kidney health. #Nephrology #Innovation
CHANCE-2 trial: In stroke pts w/ CYP2C19 LOF, ticagrelor cut stroke risk in both age groups w/ normal kidneys, but no benefit in mild impairment. #Stroke #Nephrology ow.ly/92P750WCfCu
3
🥦 What’s your go-to kidney-friendly food or healthy snack?
1
United in remembrance. Stronger together.
Clinical Trials for Pig-to-Human Kidney Transplantation Are Here. From Research to Real-World Impact! ow.ly/Wsgz50WCeOC
2
Multi-institutional study in pediatric lupus shows reliable capture of BP, proteinuria & RAAS inhibitor use across 6 sites. Findings reveal high hypertension/proteinuria rates, variation in treatment, & opportunities to standardize care. #PediatricLupus pubmed.ncbi.nlm.nih.gov/4039…
3
💊 Breakthrough in Lupus Nephritis Treatment! Results from the REGENCY phase 3 trial show that adding obinutuzumab to standard therapy significantly improved kidney outcomes in adults with active lupus nephritis. ow.ly/qE0750YTeA7
5
A dual GLP-1 & glucagon receptor agonist, significantly reduced urinary albumin-to-creatinine ratio (UACR) in patients w/ type 2 diabetes & chronic kidney disease. At 14 weeks, reductions reached ~44% w/ 300 μg & ~50% with 600 μg versus placebo, w/ effects sustained at 26 weeks.
2
🌟 Nephrology is evolving—precision medicine, advanced therapies, AI, next-gen diagnostics & whole-patient wellness are transforming kidney care. The goal: longer, healthier lives & smarter decisions for patients. #Nephrology #KidneyHealth #Innovation #PatientCare
5
🧪 Promising Results in IgA Nephropathy! A phase 3 trial shows that atrasentan, a selective endothelin A receptor antagonist, significantly reduced proteinuria in patients with IgA nephropathy and high kidney risk. #KidneyResearch 🔗 Learn more: pubmed.ncbi.nlm.nih.gov/3946…
10
2026 NephroNet Nephrology Update Conference #NephroNetLive #KidneyCare #HealthcareLeaders #ConnectLearnLead
13
Breakthrough in Lupus Nephritis Treatment! Results from the REGENCY phase 3 trial show that adding obinutuzumab to standard therapy significantly improved kidney outcomes in adults with active lupus nephritis. Read more: pubmed.ncbi.nlm.nih.gov/3992… #LupusNephritis #ClinicalTrials
11